Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.55 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.46 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.46 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.46 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13425344 | 0.83 | GAA (0.57) | ALDH1A1KMT2AMEN1TDP1KDM4E | |
| SCHEMBL18724770 | 0.81 | KMT2A (0.60) | ALDH1A1KMT2AMEN1TDP1KDM4E | |
| SCHEMBL13425486 | 0.80 | KMT2A (0.59) | ALDH1A1KMT2AMEN1TDP1KDM4E | |
| SCHEMBL7817258 | 0.79 | GPR174 (0.72) | ALDH1A1KMT2AMEN1TDP1GAA | |
| SCHEMBL16583631 | 0.74 | ALDH1A1 (0.74) | ALDH1A1KMT2AMEN1TDP1KDM4E | |
| SCHEMBL13302833 | 0.74 | ALDH1A1 (0.46) | ALDH1A1KMT2AMEN1KDM4ELMNA | |
| SCHEMBL29044382 | 0.73 | MAPT (0.73) | ALDH1A1KMT2AMEN1TDP1KDM4E | |
| SCHEMBL13302829 | 0.73 | MEN1 (0.59) | ALDH1A1KMT2AMEN1KDM4ELMNA | |
| SCHEMBL7824313 | 0.73 | GPR174 (0.60) | ALDH1A1KMT2AMEN1TDP1KDM4E | |
| SCHEMBL7012598 | 0.72 | GPR174 (0.59) | ALDH1A1KMT2AMEN1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150376224-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-12-31 | — | — | US | disclosed |
| US-20150376224-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-12-31 | — | — | US | disclosed |
| WO-2014128283-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-08-28 | — | — | WO | disclosed |
| EP-2769765-A1 | Use of compositions obtained by calcing particular metal-accumulating plants for implementing catalytical reactions | Centre National De La Recherche Scientifique (FR) | 2014-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376224-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | CACYBP, PPA1, IPMK | ALDH1A1 3184/4885KMT2A 3086/4885MEN1 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.